Mireille Caron

Title: Mireille Caron: Innovator in Glycogen Synthase Kinase Research

Introduction

Mireille Caron is a notable inventor based in Blainville, Canada. She has made significant contributions to the field of biochemistry, particularly in the study of glycogen synthase kinase 3 (GSK-3). Her innovative work has led to advancements in assay methods that are crucial for understanding this important enzyme.

Latest Patents

Mireille Caron holds a patent for "Assay methods for identifying glycogen synthase kinase 3 modulators." This patent addresses the need for effective methods and compositions for GSK-3 assays. These assays are essential for detecting glycogen synthase 3 kinase, assessing its activity, and identifying potential modulators. The patent is based on the discovery of a previously unknown interaction between GSK-3 and eukaryotic translation initiation factor 4E-binding protein 1, which serves as a substrate for both glycogen synthase kinase 3-alpha and glycogen synthase kinase 3-beta.

Career Highlights

Mireille Caron is currently associated with PerkinElmer Biosignal, Inc., where she continues her research and development in the field of biochemistry. Her work has been instrumental in advancing the understanding of glycogen metabolism and its implications in various diseases.

Collaborations

Mireille has collaborated with esteemed colleagues such as Roberto J Rodriguez-Suarez and Lucille Beaudet. These collaborations have further enriched her research and contributed to the scientific community's understanding of glycogen synthase kinase 3.

Conclusion

Mireille Caron is a pioneering inventor whose work in glycogen synthase kinase research has led to significant advancements in assay methods. Her contributions continue to impact the field of biochemistry and enhance our understanding of enzyme modulation.